SpineFrontier CFO pleads guilty in surgeon kickback scheme

BOSTON — The chief financial officer of SpineFrontier Inc., a spinal implant company formerly based in Malden, Mass., pleaded guilty Tuesday to one count of conspiracy to violate the Anti-Kickback Statute.

Per the Justice Department announcement dated May 12, 2026, the CFO admitted to participating in a scheme that paid surgeons kickbacks disguised as consulting fees to induce them to use SpineFrontier spinal devices in surgeries. The company itself was previously based in Malden before relocating operations.

The plea covers conduct that affected an undetermined number of spinal surgeries performed by surgeons who received the disguised payments. The Justice Department has not released aggregate dollar figures for the kickbacks or the value of the induced device sales.

The guilty plea requires the CFO to face sentencing in the U.S. District Court for the District of Massachusetts on a date not yet scheduled.

The conviction changes the legal status of the CFO from defendant to convicted party, exposing the individual to a statutory maximum of five years in prison and fines under the Anti-Kickback Statute provisions. Sentencing will now proceed under federal guidelines that consider the amount of remuneration and the number of patients affected.

The company itself faces separate civil and administrative exposure under the False Claims Act for any federally reimbursed procedures tied to the tainted devices.

Downstream, the plea requires the CFO to cooperate with ongoing federal investigations into other participants, including surgeons who accepted the fees. The U.S. Attorney’s Office for the District of Massachusetts must now prepare a presentence report and submit sentencing memoranda.

Hospitals and surgeons who used SpineFrontier products in federally funded procedures must review their compliance records because the conviction supplies evidence that can support False Claims Act qui tam suits or exclusion from federal health care programs.

The Centers for Medicare and Medicaid Services can use the guilty plea as grounds to pursue civil monetary penalties or suspension of payments to implicated providers.

This marks the latest enforcement action in the Justice Department’s long-running effort to prosecute kickbacks in the spinal implant sector. Similar cases have produced guilty pleas and settlements against both device makers and physicians in the District of Massachusetts and elsewhere since the mid-2010s.